DOYLESTOWN, PA--(Marketwire - November 01, 2007) - QuantRx® Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, today announced that it has launched the QuantRx Affirm Drugs-of-Abuse Test product line in both the U.S. and European markets. This product line, along with its RapidSense line, enables QuantRx to offer its customer base a complete spectrum of drugs-of-abuse test product lines.
